Redefining myeloma (Q58030074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Haematological cancer: Redefining myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Giampaolo Merlini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jesús San Miguel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

S. Vincent Rajkumar

0 references

Giampaolo Merlini

2

object named as

Giampaolo Merlini

0 references

author name string

Jesus F. San Miguel

3

0 references

language of work or name

English

0 references

publication date

31 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

494-496

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.128

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.128

A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.128

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.128

Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.128

Diagnosis of smoldering multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.128

Treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.128

Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I--a randomized study. Myeloma Group of Western Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.128

Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.128

10.1038/NRCLINONC.2012.128

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22850755%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference